NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹6,351 Cr | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr |
What is the latest Appropriations of NATCO PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹6,351 Cr |
| Mar2024 | ₹4,681 Cr |
| Mar2023 | ₹3,382 Cr |
| Mar2022 | ₹2,738 Cr |
| Mar2021 | ₹2,680 Cr |
How is Appropriations of NATCO PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,351 Cr | 35.69 | |
| Mar2024 | ₹4,681 Cr | 38.40 | |
| Mar2023 | ₹3,382 Cr | 23.51 | |
| Mar2022 | ₹2,738 Cr | 2.17 | |
| Mar2021 | ₹2,680 Cr | - | |
Compare Appropriations of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,730.4 Cr | 4.3% | 6% | -34.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 4.3% |
6% |
-34.9% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses